Tekla Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 161,418 shares of REGN stock, worth $168 Million. This represents 4.59% of its overall portfolio holdings.

Number of Shares

161,418

Previous 143,053 12.84%

Holding current value

$168 Million

Previous $118 Million 1.32%

% of portfolio

4.59%

Previous 4.51%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$700.03 - $830.35 $12.9 Million - $15.2 Million	18,365 Added 12.84%	161,418 $116 Million
Q1 2023 May 10, 2023	BUY	$680.49 - $826.97 $15.1 Million - $18.4 Million	22,191 Added 18.36%	143,053 $118 Million
Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $8.33 Million - $9.04 Million	11,800 Added 10.82%	120,862 $87.2 Million
Q3 2022 Nov 01, 2022	SELL	$573.97 - $724.32 $19.4 Million - $24.5 Million	-33,802 Reduced 23.66%	109,062 $75.1 Million
Q2 2022 Jul 29, 2022	SELL	$548.35 - $738.84 $1.83 Million - $2.46 Million	-3,336 Reduced 2.28%	142,864 $84.5 Million
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $1.88 Million - $2.2 Million	3,151 Added 2.2%	146,200 $102 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $2.7 Million - $3.33 Million	-4,966 Reduced 3.36%	143,049 $90.3 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $5.67 Million - $6.73 Million	9,883 Added 7.15%	148,015 $89.6 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $7.27 Million - $8.59 Million	-15,373 Reduced 10.01%	138,132 $77.2 Million
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $11.6 Million - $14.2 Million	-25,880 Reduced 14.43%	153,505 $72.6 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $13.4 Million - $17 Million	-28,003 Reduced 13.5%	179,385 $86.7 Million
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $10.6 Million - $12.8 Million	19,453 Added 10.35%	207,388 $116 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $8.41 Million - $11 Million	17,057 Added 9.98%	187,935 $117 Million
Q1 2020 May 14, 2020	SELL	$336.18 - $494.43 $10.2 Million - $15 Million	-30,399 Reduced 15.1%	170,878 $83.4 Million
Q4 2019 Feb 13, 2020	BUY	$274.13 - $376.51 $11.4 Million - $15.7 Million	41,619 Added 26.07%	201,277 $75.6 Million
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $2 Million - $2.33 Million	-7,310 Reduced 4.38%	159,658 $44.3 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $7.62 Million - $10.6 Million	25,436 Added 17.97%	166,968 $52.3 Million
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $1.9 Million - $2.25 Million	5,110 Added 3.75%	141,532 $58.1 Million
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $3.3 Million - $3.96 Million	-9,815 Reduced 6.71%	136,422 $51 Million
Q2 2018 Aug 13, 2018	BUY	$284.6 - $344.99 $1.9 Million - $2.3 Million	6,677 Added 4.78%	146,237 $50.5 Million
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $9.78 Million - $12.2 Million	-30,956 Reduced 18.15%	139,560 $48.1 Million
Q3 2017 Nov 13, 2017	SELL	$431.38 - $504.0 $7.4 Million - $8.64 Million	-17,150 Reduced 9.14%	170,516 $76.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	187,666	187,666 $92.2 Million

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History